NCT05426031View on ClinicalTrials.gov

Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Coagulation; Intravascular
Interventions
DRUG

Protamine fixed dose

250 mg of protamine intravenously (IV), one time use

DRUG

Protamine ratio dose

1mg of protamine per 100 units of heparin given intravenously (IV), one time use

Trial Locations (2)

33136

University of Miami Hospital, Miami

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER